Ou MC et al. |
Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure. |
1994 |
Thromb. Res. |
pmid:8191415
|
Eche N et al. |
Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). |
1986 |
Thromb. Res. |
pmid:3726808
|
Slattery CW and Beaumont DO |
Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors. |
1989 |
Thromb. Res. |
pmid:2554526
|
Nguyên P et al. |
Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. |
1995 |
Thromb. Res. |
pmid:7778064
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Namm DH and High JA |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. |
1980 |
Thromb. Res. |
pmid:7209881
|
Hanss M and Dechavanne M |
48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. |
1988 |
Thromb. Res. |
pmid:3126559
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Shukla SD et al. |
Hypersensitivity of diabetic human platelets to platelet activating factor. |
1992 |
Thromb. Res. |
pmid:1329254
|
Kurose I et al. |
Involvement of superoxide anion and platelet-activating factor in increased tissue-type plasminogen activator during rat gastric microvascular damages. |
1991 |
Thromb. Res. |
pmid:1650966
|
Westwick J et al. |
Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. |
1986 |
Thromb. Res. |
pmid:3715810
|
Valone FH |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. |
1987 |
Thromb. Res. |
pmid:3590086
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Ishii H et al. |
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation. |
1990 |
Thromb. Res. |
pmid:2382255
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Hofmann B et al. |
Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. |
1988 |
Thromb. Res. |
pmid:3381200
|
Cox CP and Wood KL |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. |
1987 |
Thromb. Res. |
pmid:3629553
|
Catalán RE et al. |
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug. |
1994 |
Thromb. Res. |
pmid:7974386
|
Ostermann G et al. |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. |
1987 |
Thromb. Res. |
pmid:3629555
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Petty AC and Scrutton MC |
Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? |
1989 |
Thromb. Res. |
pmid:2749609
|
Janero DR et al. |
Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet. |
1988 |
Thromb. Res. |
pmid:3413730
|
Moon DG et al. |
Platelet activating factor and sheep platelets: a sensitive new bioassay. |
1990 |
Thromb. Res. |
pmid:2326773
|
Violi F et al. |
Human platelet aggregation by PAF and thromboxane production. |
1987 |
Thromb. Res. |
pmid:3424290
|
Klöcking HP et al. |
Release of tissue-type plasminogen activator by platelet-activating factor. |
1985 |
Thromb. Res. |
pmid:4040278
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Vrzheshch PV et al. |
Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets. |
1992 |
Thromb. Res. |
pmid:1523610
|
Teng CM et al. |
Antiplatelet actions of some coumarin compounds isolated from plant sources. |
1992 |
Thromb. Res. |
pmid:1523611
|
Kohayakawa M and Inoue K |
Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. |
1986 |
Thromb. Res. |
pmid:3083530
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Hadváry P and Baumgartner HR |
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor. |
1983 |
Thromb. Res. |
pmid:6868019
|
Leoncini G et al. |
Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. |
1997 |
Thromb. Res. |
pmid:9175236
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Despotis GJ et al. |
Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood. |
1997 |
Thromb. Res. |
pmid:9175242
|
Ding YA et al. |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. |
1995 |
Thromb. Res. |
pmid:7740521
|
Bussolino F et al. |
Intravascular release of platelet activating factor in children with sepsis. |
1987 |
Thromb. Res. |
pmid:3441909
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Pfliegler G et al. |
Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products. |
1993 |
Thromb. Res. |
pmid:8503122
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Lecompte T et al. |
Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP. |
1990 |
Thromb. Res. |
pmid:2117306
|
McGowan EB and Detwiler TC |
Characterization of the thrombin-induced desensitization of platelet activation by thrombin. |
1983 |
Thromb. Res. |
pmid:6356458
|
Mabilat-Pragnon C et al. |
Urokinase localization and activity in isolated eosinophils. |
1997 |
Thromb. Res. |
pmid:9526961
|
May JA et al. |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. |
1997 |
Thromb. Res. |
pmid:9361371
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|